|
| Press Releases |
|
 |
|
| Tuesday, August 31, 2021 |
|
|
创梦天地公布 2021年中期业绩 |
| 创梦天地科技控股有限公司（「创梦天地」或「公司」，连同其附属公司统称「集团」；股份代号：1119.HK）欣然宣布截至2021年6月30日止六个月（「期内」）的未经审核综合中期业绩。 more info >> |
|
|
創夢天地公佈 2021年中期業績 |
| 創夢天地科技控股有限公司（「創夢天地」或「公司」，連同其附屬公司統稱「集團」；股份代號：1119.HK）欣然宣佈截至2021年6月30日止六個月（「期內」）的未經審核綜合中期業績。 more info >> |
|
|
iDreamSky Announces 2021 Interim Results |
| iDreamSky Technology Holdings Limited ("iDreamSky", or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1119.HK) is pleased to announce its unaudited interim results for the six months ended 30 June 2021 ("the Reporting Period"). more info >> |
|
| Monday, July 12, 2021 |
|
|
騰訊加持，券商看好，線下店業務潮玩業態可期 |
近段時間港股大市表現不佳，但創夢天地（1119.HK）卻在基本面的支撐下，走出了亮眼漲勢。投資者連呼“後悔沒早點發現”。該公司有何優秀特質，在高度有效定價的港股市場，竟能逆市上漲成大牛股？
more info >> |
|
|
腾讯加持，券商看好，线下店业务潮玩业态可期 |
近段时间港股大市表现不佳，但创梦天地（1119.HK）却在基本面的支撑下，走出了亮眼涨势。投资者连呼“后悔没早点发现”。该公司有何优秀特质，在高度有效定价的港股市场，竟能逆市上涨成大牛股？
more info >> |
|
| Tuesday, June 8, 2021 |
|
|
iDreamSky Technology (1119.HK) Lifetime Value (LTV) seriously undervalued, upside 65% |
| Anli released its first coverage research report, giving iDreamSky Technology (1119. HK) a 'buy" rating with a target price of HK $7 per share, up 63% from HK $4.3 per share on June 3. more info >> |
|
| Wednesday, August 26, 2020 |
|
|
创梦天地2020年中期收入增长11.2%达人民币1,592百万元 |
| 创梦天地科技控股有限公司（「创梦天地」或「集团」）公布截至2020年6月30日止（「期内」）之未经审核中期业绩。 more info >> |
|
|
創夢天地2020年中期收入增長11.2%達人民幣1,592百萬元 |
| 創夢天地科技控股有限公司（「創夢天地」或「集團」）公佈截至2020年6月30日止（「期內」）之未經審核中期業績。 more info >> |
|
|
iDreamSky's 2020 Interim Revenue Increases 11.2% to RMB1,592 million |
| iDreamSky Technology Holdings Limited ("iDreamSky", or the "Group", stock code: 1119) announced its unaudited consolidated results of the Group for the six months ended June 30, 2020. more info >> |
|
| Wednesday, March 18, 2020 |
|
|
创梦天地收购成功机率增加 未来协同效应巨大 |
| 早前，创梦天地(1119.HK)宣布拟收购乐游科技控股(1089.HK)69.21%股权，惟有关是次收购事项的排他协议多次延长，引发市场疑问此笔交易或不能达成。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 23:21 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 23:18 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 23:03 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 22:33 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 22:31 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 21:32 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 21:30 HKT/SGT
|
|
|
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT/SGT
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 21:24: JST
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT/SGT
|
|
|
NMPA已受理億勝生物關於EB12-20145P（HLX04-O）用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Aug 13, 2025 20:24 HKT/SGT
|
|
|
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
Aug 13, 2025 19:19 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 13:00: JST
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
